Código QR (código de barras bidimensional)

Current Status and Prospect of PD-1/PD-L1 Immune Checkpoint Inhibitor Therapy 
in Elderly Patients with Advanced NSCLC

The incidence of cancer is closely correlated with age, as 75% of non-small cell lung cancer (NSCLC) patients are aged at least 65 years. The availability of immune checkpoint inhibitors (ICIs) has altered the available NSCLC therapeutic pattern. Limited studies on elderly patients have demonstrated...

Fuld beskrivelse

Na minha lista:
Principais autores: Yunye MAO, Shu SHENG, An WANG, Jinzhao ZHAI, Xiangwei GE, Di LU, Jinliang WANG
Format: Artigo
Sprog:Chinês
Udgivet: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2024-05-01
Serier:Chinese Journal of Lung Cancer
Fag:
lung neoplasms
elderly non-small cell lung cancer
immunosenescence
immunotherapy
immunotherapy combined with low-intensity chemotherapy
Online adgang:http://dx.doi.org/10.3779/j.issn.1009-3419.2024.106.10
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker